Skip to main content

CBD Life Sciences, Inc. (CBDL) Debuts New Exclusive Delta-8 Product

SCOTTSDALE, AZ / ACCESSWIRE / December 14, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company is introducing new powerful Delta-8 gummies.

LBC Bioscience Inc. has been actively developing and producing new exclusive products to satisfy customers and this product is over the top outstanding! The reinvented gummies the company is introducing are Crisp Green Lush Apple flavored power packed with 100MG of the Purest Delta-8 THC per 1 gummy. All jars will contain 20 gummies equaling out to 2000MG total in each packaged jar. LBC's gummies use a harmonizing 2:1 blend of CBD and Delta-8 to achieve an overall balanced, elevated experience. Overall, this specific gummy is ideal for calming the mind while staying extremely focused all at the same time! All products made by LBC Bioscience are carefully blended to ensure maximum consistency along with top-tier Third Party Lab Testing for verification. This product will be available in store immediately in addition to online at https://www.lbcbioscienceinc.com within the next couple of weeks. President & CEO Lisa Nelson states, "LBC is always one step ahead of competitors with its mass variety of products and we are thrilled to be able to launch this product to consumers right away!"

The number of benefits CBD has is tremendous! These benefits may help with behavioral/neurological complications such as ADD/ADHD, anxiety, autism, bipolar, OCD, PTSD, epilepsy, Parkinson's, osteoporosis, and ALS. CBD may also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn's, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension even our bodies way and ability to maintain homeostasis have all been said to receive help from CBD. More news to come!

CBD Life Sciences, Inc., Wednesday, December 14, 2022, Press release picture

LBC BIOSCIENCE INC. ONLINE STORE

LBC BIOSCIENCE'S Online Emporium

LBC Bioscience Inc. is well stocked already as it is with some very high-quality CBD offerings - all at very reasonable prices. Check out LBC Bioscience Inc's newest product offerings including its: 100MG CBD Bath Bombs in a variety of scents, Delta 8 Gummies, 1500 MG Premium Berry Drops, and a variety of all-new Skincare products. Or shop our top-selling products (based on order frequency) which include our CBD Pain Cream, CBD Oils and CBD Pet Treats.

Become a Distributor

https://www.lbcbioscienceinc.com/wholesale

Large Selection of Products (over 50 items and growing)

100% USA Made Products "organic & kosher."

All Products are THC-FREE (they contain 0.00% THC)

LBC Bioscience Inc. accepts: Visa, MasterCard, American Express, Discover etc.

Shareholders and interest holders may also stay current with LBC Bioscience Inc Updates:

LBC Bioscience Inc's Main Website at www.lbcbioscienceinc.com

Twitter: https://www.twitter.com/lbcbioscience

Facebook: https://www.facebook.com/lbcbioscience

Instagram: https://www.instagram.com/lbcbioscience

About LBC Bioscience Inc.

LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including CBD Drops, Gumballs, Honey Sticks, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets and more. LBC's products can be viewed and bought on the Company's website at www.lbcbioscienceinc.com.

Ten Associates LLC

Contact: Thomas E. Nelson

Telephone: (480) 326-8577

Email: tenassociates33@gmail.com

Website: www.tenassociatesllc.com

Forward-Looking Statements

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement

This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking

SOURCE: CBD Life Sciences Inc.



View source version on accesswire.com:
https://www.accesswire.com/731736/CBD-Life-Sciences-Inc-CBDL-Debuts-New-Exclusive-Delta-8-Product

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.